AstraZeneca (AZN) is in exclusive final talks to sell its Swedish healthcare and dental unit...


AstraZeneca (AZN) is in exclusive final talks to sell its Swedish healthcare and dental unit Astra Tech to Dentsply (XRAY) in a transaction that could value the subsidiary at about $1.8B, sources say. Dentsply has outbid private equity group EQT Partners, medical company Biomet and others.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs